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Cells of acute myeloid leukemia (AML) from C3H/He mice express an increased amount of RNA for an endogenous
retrovirus-like retrotransposon, intracisternal A-particle element. We analyzed the transcription of other mouse retrotrans-
posons in C3H-derived tumor cells and found that all the AML lines from different mice overexpress early-transposon (ETn)
RNA. In contrast, only faint levels of ETn were detected in the cells from other tumors, including hepatoma and lymphoma.
The polyadenylation sites of the ETn RNA in the AML cells varied. We also determined the binding site for the nuclear extract
of the AML cells in the long terminal repeat sequence of ETn. The overexpression of ETn as a common phenotype of AML
cells suggests that myeloid cells with this phenotype are the origin of all the AML cells or that the phenotype is acquired
during leukemogenesis. © 2001 Academic Press
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The murine genome possesses various retrovirus-like
retrotransposons (Keshet et al., 1991). Early transposon
(ETn) is present at 200 copies per genome, is approx 5.7
kb in size, and has two long terminal repeats (LTRs) at
both ends (Brulet et al., 1983). Its structure indicates that
ETn is amplified by the accumulation of retrotransposi-
tions, a series of transcription, reverse transcription, and
integration events, in germ-line cells. Since no open
reading frames are detected in the nucleotide sequence
and the distribution in the genomes is consistent with
mouse phylogeny (Sonigo et al., 1987), it is believed that
the ETn elements are positioned between the retrotrans-
poson and the repetitive sequence (Keshet et al., 1991).
Unlike other retrotransposons, intracisternal A-particle
(IAP) and virus-like 30S elements, ETn is rarely ex-
pressed in cell lines (Keshet et al., 1991). An enhanced
expression is observed only in the normal cells of early
embryo (Brulet et al., 1985), a teratocarcinoma cell line
(Brulet et al., 1983), and several plasmacytoma cell lines
(Shell et al., 1987). Although retrotransposition of ETn is
found in several mutant mice (Steinmeyer et al., 1991;
Adachi et al., 1993; Schnulle et al., 1997; Moon and
Friedman, 1997; Hoffmann et al., 1998; Tien and Ruther,
1999) and tumor cell lines (Shell et al., 1987, 1990; Mit-
reiter et al., 1994), the expression level of ETn is not
significant. However, we found new accumulations of
1 To whom reprint requests should be addressed. Fax: 181-43-255-
819. E-mail: ishihara@nirs.go.jp.
107ETn message in all the acute myeloid leukemia (AML)
cells from different individuals of C3H/He inbred mice.
AML is generated in C3H/He inbred mice 1–2 years
after whole-body X-irradiation at sublethal doses (Seki et
al., 1991). AML cells with various histochemical pheno-
types have been isolated from mice (Yoshida et al., 1986).
We previously found that retrotransposition of IAP ele-
ment occurs in all the AML cells from different individu-
als (Tanaka and Ishihara, 1995; Ishihara and Tanaka,
1997). In the C3H inbred mice, normal cells possess a
large amount of IAP RNA. Additional expression of one
type of IAP was found in all the leukemia cells (Ishihara
et al., 2000). In this study, RNAs of other retrotrans-
posons, VL30 and ETn, were compared in several tumor
cells. In the C3H-derived tumors, all the AML cells pos-
sessed high levels of ETn RNA, though only a small
amount of ETn RNA was detected in hepatoma, lym-
phoma, and normal cells.
As in retroviruses, transcription in most retrotrans-
posons is regulated by their LTR sequences. ETn LTR
can be classified as a U3-R-U5 substructure with simi-
larity in nucleotide sequence and structure to the ETn
RNA (Kaghad et al., 1985). However, the mechanism of
regulating ETn expression is poorly understood. In the
present study, the nucleotide sequence of ETn RNA and
specific binding of nuclear protein to LTR were com-
pared in AML cells.
RESULTS
Our previous study demonstrated that the transcript of
one type of IAP element increased in AML cells derived
from different individuals (Ishihara et al., 2000). This
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108 TANAKA AND ISHIHARAsuggests that the expression mechanism(s) of the retro-
transposon is deregulated in myeloid leukemia cells. To
examine this possibility, we analyzed the expression of
retrotransposons not only in the AML strains used in our
previous study, but also in other tumor cells by conven-
tional analyses.
Expression of retrotransposons ETn and VL30 in
murine tumors
We first analyzed the expression of retrotransposon
ETn and found an increase in ETn RNA in all the myeloid
leukemia cells tested (Fig. 1). Although only a small
amount of ETn RNA was observed in the normal cells of
C3H mice, large amounts were detected in primary and
linearized leukemia cells of various phenotypes from
different individuals. In contrast, no such enhancement
of the message was detected in any of the 12 primary
hepatic tumor cells and fibloblast cell lines (L.P3 and
L929) from C3H mice and 10 primary lymphoma cells
from C57BL10 mice (part of the results are shown in Fig.
FIG. 2. Expression of retrotransposons in C3H-derived hepatoma
and tumors from other mouse strains. Normal liver from two mice and
thymus from three mice were used as controls. RNA samples from four
hepatomas from C3H mice and four thymic lymphomas of C57 mice
were used. Fibroblastic cell lines from C3H (L.P3 and L929) and
myeloid tumor cell lines based on Balb/c (WEHI-3 and J774.1) were also
analyzed. An aliquot of RNA (10 6 1 mg/lane) was electrophoresed in
FIG. 1. Expression of retrotransposons ETn and VL30 in AML cells.
As a control, the tissues from three mice (lanes 1 to 3) were prepared
separately. Cells of primary AMLs and AML strains were prepared from
enlarged spleen. An aliquot of RNA (10 6 1 mg/lane) was electropho-
resed in triplicate, and Northern blot hybridization with ETn LTR, VL30
LTR, and b-actin was performed.triplicate, and Northern blot hybridization with ETn LTR, VL30 LTR, and
b-actin was performed.2). In the myeloid tumor from Balb/c mice, ETn expres-
sion was found in WEHI-3 but not in J774.1 cell lines.
Meanwhile, expression levels of VL30 varied not only in
the leukemia cells but also in normal tissue. Enhanced
expression of VL30 was observed in a liver from mouse
2, several leukemia cells (Fig. 1), and lymphoma cells
(Fig. 2). However, diminution of the VL30 RNA was also
found in several tumor cells. This shows that the myeloid
leukemia cells from different individuals of C3H/He in-
bred mice have a feature in common in the expression of
ETn.
Structure of ETn RNA expressed in myeloid leukemia
To confirm that the ETn RNA expressed in leukemia
cells is the full-length type, Northern blot hybridization
using probes specific to the internal sequence of ETn
was conducted (Figs. 3a and 3b). Since the variations in
FIG. 3. Analysis of ETn RNA. (a) Map of a typical ETn element. LTRs
are denoted as open arrows. Short R regions in the LTRs correspond to
vertical bars inside the arrows. The internal area of ETn is indicated as
a bold line. Open boxes mean sites corresponding to probes for
Northern blot hybridization. The positions and directions of RT-PCR
primers are indicated as small arrows. (b) Northern blot hybridization
probed with internal sequence of ETn. For each membrane, 10 6 1
mg/lane of RNA sample was used. The four internal sequences indi-
cated were used as probes. (c) RT-PCR analysis. Poly(A)1 RNA was
everse transcribed and PCR-amplified using the primers indicated in
. The PCR products were electrophoresed in a 2% agarose gel and
tained with ethidium bromide.the size of ETn messages were minimal, the ETn RNA
f
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109OVEREXPRESSION OF ETn IN MURINE MYELOID LEUKEMIA CELLSdetected in Northern blots was not a deleted type nor a
readthrough transcript of any other gene. RT-PCR analy-
ses using primers specific to the internal sequence also
showed that ETn RNA without deletion in the internal
sequence was expressed in these leukemia cells (Fig.
3c). This is consistent with the fact that no deleted type
of ETn has been reported, unlike a deleted IAP element.
In one of the leukemia lines, L8065, a slight difference in
RNA size was found by Northern bloting (Fig. 3b). Since
FIG. 4. Nucleotide sequence comparison of ETn LTRs. (A) The nucleoti
top of each block. Corresponding sequences from other genomic clones
(M15598) are aligned and bases different from N01 are shown. A hyphen d
R, and U5 regions (Kaghad et al., 1985) are also indicated at the top. (B) N
rom spleen RNA (C5a to d) and leukemia L8072 RNA (L5a to d) are align
pleen (C3a to g), L8072 (L3a to h), and L8028 (L4a to h) are aligned witha similar difference was not observed by PCR (Fig. 3c),these leukemia cells probably stimulate ETn elements
with different LTR sequences.
Comparison of LTR sequences of ETns
It has been reported that there are two subfamilies of
ETns with different nucleotide sequences in the LTR in
the genome of the Balb/c mouse, MG1 and RMg2 (Shell
et al., 1990). We isolated six clones containing ETn ele-
ments from a genomic DNA library of C3H/He mouse
ence of ETn LTR from one of the C3H/He genomic clones (N01) is at the
03, and S01 to S03), MG1 type (Accession No. M16478), and RMg2 type
deleted bases compared to N01. Numbers and sites of the predicted U3,
de sequences of the 59 end of the ETn cDNA clone analyzed by 59 RACE
a genomic N01 clone. (C) 39 ends of ETn of 39 RACE cDNA clones from
and C3H genomic clones (S01 and N01).de sequ
(N02, N
enotes
ucleoti
ed withand sequenced the LTR (Fig. 4A). Three of six clones
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110 TANAKA AND ISHIHARAwere very similar to the MG1 sequence (DDBJ/EMBL/
GenBank Accession No. M16487), with only 4, 7, or 9 of
322 nucleotides different. In contrast, similarities of these
LTR sequences to the RMg2 type were approx 80%.
Another three clones were identical to the MG1, except
for a deletion of 9 nucleotides in the middle of the LTR.
Since the deletion site was closely linked to the putative
TATA box (Kaghad et al., 1985), the ETn element is pre-
umed to be a transcriptionally inactive form.
ETn transcripts were also cloned from RT-PCR prod-
cts of normal spleen and myeloid leukemia L8072 cells
nd sequenced. Since nucleotide sequences of the U3,
, and beginning of the U5 region of the MG1 and RMg2
ypes of ETns were identical (Fig. 4A), it is expected that
heir transcriptions are regulated by a common mecha-
ism. As information on the nucleotide sequence of
Mg2 was limited, data from MG1 were used to synthe-
ize oligonucleotides for the 59 RACE analyses. To iso-
late the 59 and 39 ends of the ETn RNA, 59 RACE and 39
RACE were performed. When the nucleotide sequences
of four different 59-RACE clones from normal and leuke-
mia cells were compared (Fig. 4B), it was found that all
the clones were identical to the MG1 subfamily and were
initiated from the same position in the putative R region
(Kaghad et al., 1985).
To analyze sequences adjacent to the poly(A) site at
the 39 end of the RNA, seven clones from normal spleen
and eight clones from L8072 leukemia cells were iso-
lated after 39-RACE PCR. Excluding clone C3d, the ends
of the U3–R sequence of all of the clones from normal
cells were closely related (Fig. 4C). When the poly(A)
sites were compared, greater variation in ETn RNAs from
AMLs was found. In the case of ETn RNA from normal
cells, two, four, and one of seven clones were polyade-
nylated at 0, 11, and 12, from the end of the R region,
respectively. Even though correspondence with the pu-
tative poly(A) site was observed in two of eight clones in
ETn RNAs from AML cells, adenylation occurred at 28,
24, 23, 13, 13, and 17 from the end of the R region in
six clones (Fig. 4C, L3a–h). We also analyzed poly(A)
sites among eight clones of ETn RNA from L8028 leuke-
mia cells, and found similar variation of adenylation at
12, 13, 14, 22, 17, and 17 in six clones (Fig. 4C,
L4a–h). This suggests heterogeneity of the polyadenyla-
tion of ETn transcripts in leukemia cells.
Specific binding site in the ETn LTR of the nuclear
protein present in the AMLs
Although transcriptional start and termination sites of
the ETn element are predicted from the RNA and nucle-
otide sequence analyses (Kaghad et al., 1985; Sonigo et
al., 1987), no evidence has been reported for the regula-
tion of ETn expression. We analyzed the specific binding
of the nuclear extract of the AML cells to the LTR se-
quence by electrophoretic mobility-shift assay (EMSA).As shown in Fig. 5a, 11 dsDNA fragments corresponding
to U3–R regions of ETn LTR were synthesized. Nuclear
extracts from two leukemia cells or normal spleen cells
were mixed with the DNA fragments and were electro-
phoresed.
A DNA fragment corresponding to position 8 of the LTR
was bound to nuclear extracts from L8072 and L8065
leukemia cells (Fig. 5b). Retardation of the band with a
weak intensity was found at position 7 in L8072 and
position 9 in both leukemia cells. In contrast, no retar-
dation was detected when the extract from normal
spleen cells was used. The retardation of bands disap-
peared when the nuclear extracts were pretreated with
proteinase K and when the binding reaction was done in
the presence of unlabeled oligonucleotides as competi-
tors (Fig. 5c). The data show that the nuclear protein in
leukemia cells binds specifically to position 8 of the ETn
LTR sequence. Although the center of the binding target
sequence was compared with databases using Signal
Scan (NIH) and TFSEARCH (genome NET, Japan), no
significant functional motif was found.
DISCUSSION
ETn is regarded as a retrotransposon expressed at the
early stage of embryogenesis in normal cells and in
teratocarcinoma that reflects the nature of the early em-
bryo (Brulet et al., 1983, 1985). In C3H-derived tumor, the
full-length ETn RNA was clearly expressed in all the AML
cells, but not in hepatic tumors, fibroblasts, or normal
cells (Figs. 1, 2, and 3). Among the Balb/c-derived cell
lines, the ETn RNA level was elevated in WEHI-3 myeloid
leukemia cells but not in J774.1 macrophage-like cells
(Fig. 2). Similarly, it has been reported that not all, but a
number of, B-cell tumors express ETn RNA (Shell et al.,
1987). In C57BL6-derived tumors, no such enhancement
was found in the thymic lymphoma cells (Fig. 2). This
suggests that the enhanced expression of ETn RNA is
due not only to the cell type but also to the genetic
background of the inbred mice.
Interestingly, all the C3H-derived AML cells also ex-
pressed an increased amount of the retrotransposon IAP
RNA that possesses a unique LTR (Ishihara and Tanaka,
1998; Ishihara et al., 2000). Similarly, accumulation of the
IAP RNA and IAP-mediated retrotransposition was ob-
served in WEHI-3 (Blatt et al., 1989). In contrast, variation in
the expression level of VL30 RNA was found among tumor
and normal cells tested, as previously reported (Carter et
al., 1986; Nilsson and Bohm, 1994; van der Houven van
Oordt et al., 1999). The sequences for the transcriptional
enhancer in the IAP LTR (Satyamoorthy et al., 1993) were
not detected in the ETn LTR (Fig. 5). Additionally, normal
hematopoietic cells of C3H with a small amount of ETn RNA
express an enhanced amount of IAP RNA (Ishihara et al.,
2000). This means that different mechanisms for the ex-
, positio
111OVEREXPRESSION OF ETn IN MURINE MYELOID LEUKEMIA CELLSpressions of IAP and ETn are simultaneously activated in
the AML cells.
ETn expression as a common phenotype of C3H-
derived AML cells
In the AML from C3H/He mice, all the strains and lines
commonly expressed ETn RNA, even though they were
derived from different mice and possessed various his-
tochemical phenotypes. With AML cells it is important to
consider myeloid cell differentiation and leukemogene-
sis. One possibility is that the ability to express ETn is
independent of the leukemogenesis. Since each AML
cell originates from a single myeloid stem cell, the nor-
mal stem cell expresses a large amount of ETn RNA. The
presence of a such stem cell is not consistent with the
fact that the polyadenylated ETn RNA is detected by 39
RACE and RT-PCR in normal spleen cells (Figs. 3, 4b, and
4c), although it is hard to detect by Northern blot analysis
FIG. 5. Binding of ETn LTR sequence to the nuclear extracts. (a) T
oligonucleotides for EMSA (numbered open boxes) are shown at the
oligonucleotides are indicated by bars. (b) Mixtures of the end-labele
leukemia strains (L8072 or L8065) were used for the EMSA assay unt
retarded are shown (B). (c) Binding of the L8065 nuclear extract with o
of unlabeled oligonucleotide (2, position 7; 3, position 8; 4, position 9; 5
mg/L for 10 min at 30°C) was used in lane k.(Figs. 1 and 3b). If so, a myeloid stem cell that expressesETn RNA should be able to be transformed among dif-
ferent C3H mice.
Another possibility is that the increase in the ETn
expression is acquired during or after leukemogenesis.
An enhancement of the expression of ETn RNA seems to
impart no advantages for the transformation in the cells,
because there is no open reading frame in ETn. This
suggests that activation of an undetermined mechanism
that is necessary for leukemic transformation simulta-
neously causes the accumulation of ETn RNA. Since ETn
expression is not found in any of the hepatomas and
fibloblasts (Fig. 2), the mechanism probably is specific
and common to all AML cells. In any case, the expres-
sion of ETn can be used to study myeloid differentiation
or leukemogenesis in C3H mice.
Characterization of ETn transcripts
We also compared nucleotide sequences of ETn RNAs
LTR (arrow), the nucleotide sequence (typed in the arrow), and the
magnified nucleotide sequence is also shown and the sites of the
nucleotides (1–11 as shown in a) and nuclear extract from spleen or
NAs (F) were removed from the gel. Areas of gels where bands are
leotide of position 8 was tested in the presence of a 100-fold amount
n 10) as competitor. Nuclear extract pretreated with proteinase K (100he ETn
top. A
d oligo
il free D
ligonucfrom normal and AML cells. A comparison of 59-RACE
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112 TANAKA AND ISHIHARAclones showed that all of them are transcribed at the
same position as reported (Kaghad et al., 1985) (Fig. 4b).
n contrast, a variation in the poly(A) site at the 39 end of
Tn RNA was observed among 39-RACE clones (Fig. 4c).
n seven cDNA clones from normal cells, polyadenylation
hifted 0 to 2 nucleotides downstream from the predicted
–U5 junction. The poly(A) site varied further in RNA from
wo different strains of AML cells. Shifts from position 17
o 21 were found among eight clones from L8072 and
ight clones from L8028, respectively. This means that
he machinery of polyadenylation does not function strin-
ently to process ETn RNA in AML cells. The variation in
he poly(A) site among the RNA population is not clear,
ince it has been studied neither in retrotransposons nor
n other genes. In the case of the other retrotransposon,
AP RNA, such a larger variation is not found between the
ame AML cells and normal spleen cells of C3H mice
unpublished data), even though the IAP RNA is highly
ccumulated in these C3H-derived myeloid cells (Ishi-
ara et al., 2000). Both the unexpected level of expres-
ion of ETn and the deficiency in the function of ETn
robably caused the variation in the processing of RNA
o be limited to the ETn RNA in AML.
otential and effect of ETn retrotransposition
Other common features in AML cells are an increased
xpression of one type of IAP element (Ishihara et al.,
000) and IAP-mediated retrotransposition (Ishihara and
anaka, 1997). An IAP LTR inserted by retrotransposition
ffects the gene positioned by the integration site, since
he LTR possesses a cis-reacting function (Satyamoorthy
t al., 1993). Many examples exist of IAP-mediated ret-
otransposition in tumor cell lines and mutant mice in
hich the gene located adjacent to the integration site is
ctivated (Keshet et al., 1991; Kuff and Lueders, 1988),
although the transposition frequency in tumor was esti-
mated to be low (Heidmann and Heidmann, 1991).
In the case of ETn, no such enhancer function was
detected in the LTR. Furthermore, retrotransposition of
the ETn element is found only in a limited number of cell
lines (Shell et al., 1987, 1990; Mitreiter et al., 1994) and
mutant mice (Steinmeyer et al., 1991; Adachi et al., 1993;
chnulle et al., 1997; Moon and Friedman, 1997; Hoff-
ann et al., 1998; Tien and Ruther, 1999). In these mu-
ants, the effect of the transposition was due to the
eneration of alternative splicing products without en-
ancement of transcription. In the case of the plasmacy-
oma, a specific cellular function of B-lineage cells in
ene rearrangement may contribute to the retrotranspo-
ition, since the ETn element was integrated in the im-
unoglobulin switch region and additional switch-re-
ated recombination occurred (Shell et al., 1987; Elenich
nd Dunnick, 1991). Even though integration of an ETn
TR-like sequence was also detected near an aromatase
ene in mammary tumor cells (Durgam et al., 1995), no larked enhancement in the presence of ETn was found.
hus, the effect of the retrotransposition of the ETn,
nlike the IAP, element on the cellular function is imper-
eptible in the AML cells.
echanisms to express ETn
Little is known about the mechanism behind the stim-
lation of ETn RNA and biological meaning of the early
mbryo-specific expression. Similarly, it is not clear
hether the mechanisms differ between embryo and
ML cells. We found binding activity for the ETn LTR in
uclear extract of AML cells (Fig. 5). The binding was
ost effective when the oligonucleotide possessed a
T-rich sequence in the middle of the target site (Figs. 5a
nd 5b), which corresponds to the U3 end close to the
ranscriptional initiation site (Kaghad et al., 1985). Al-
hough there were slight differences in EMSA profiles
etween nuclear extracts from the two leukemia lines,
he same oligonucleotide showed significant binding.
he specificity of the binding of the CT-rich nucleotide
nd nuclear protein was confirmed by pretreatment of
he nuclear extract with proteinase and by the competi-
ion assay (Fig. 5c); however, we could not detect a
imilar enhancer sequence in the database. Since ETn
NA accumulates only in the AML and embryonic cells,
t is expected that this specific binding contributes di-
ectly or indirectly to the enhanced expression of ETn in
developmental stage- and/or AML-specific manner.
he data in this study can be used to analyze these
egulatory mechanisms in embryo and myeloid cells.
The activation of the ETn LTR interfered with the genes
ositioned close to the LTRs. It is estimated that 200
opies of the ETn LTR and related sequences are dis-
ersed in the genome. The distribution of the ETn LTR in
he genome is poorly understood, with the exception of a
ew findings (Durgam et al., 1995; Hirose et al., 1995).
owever, it is reasonable to predict the presence of a
ene involved in myeloid differentiation and activated by
Tn, since cells of all the AML strains in C3H commonly
xpressed ETn RNA.
MATERIALS AND METHODS
ice and tumor cells
C3H/HeJ and C57BL10 inbred mice (10 weeks of age)
roduced at our institute were used as sources of normal
ells. Primary myeloid leukemia cells were induced in
he C3H mice 1–2 years after whole-body X-irradiation at
Gy (Yoshida et al., 1986) and isolated from spleen. The
yeloid leukemia lines L8002, L8028, L8065, and L-8072
Ishihara et al., 2000) used in this study were established
y in vivo passage of the primary leukemia cells more
han five times (Hayata et al., 1983; Seki et al., 1991;
shihara et al., 1993). They were prepared from the en-
arged spleens of mice 2–4 weeks after intravenous
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113OVEREXPRESSION OF ETn IN MURINE MYELOID LEUKEMIA CELLSinjection of the leukemia cells. Spontaneous hepatic tu-
mors isolated from C3H/HeJ mice ages 2–3 years were
obtained from K. Nojima of our Institute. Primary thymic
lymphoma cells induced by radiation in C57BL10 mice
were a gift from Dr. M. Muto (Muto et al., 1990). For
established cell lines, WEHI-3, J774.1, L929, and L.P3
(RIKEN RCB0035, RCB0434, RCB0081, and RCB0101)
were used.
Northern and RT-PCR analyses
RNA samples were prepared by the guanidium hot-
phenol method and were analyzed by Northern blot hy-
bridization following glyoxylation (Maniatis et al., 1982). A
VL30 probe was prepared by an amplification of C3H
genomic DNA using a pair of PCR primers corresponding
to position 16 to 35 and position 703 to 684 of a sequence
with Accession No. M21123 (Adams et al., 1988) in the
DDBJ/EMBL/GenBank nucleotide sequence database.
Probes specific to ETn were amplified from C3H mouse
genomic DNA by PCR using the following primers which
were designed based on the sequence with Accession
No. M16478 (Sonigo et al., 1987): primer 2f, correspond-
ing to 653–673; primer 3r, 992–969; primer 4f, 1881–1905;
primer 5r, 2209–2185; primer 6f, 3324–3347; primer 7r,
3560–3629; primer 8f, 4616–4635; primer 9r, 4938–4919;
primer LTRF, 7–26; primer LTRR, 306–286. Using the
primer set of LTRF and LTRR, the ETn LTR probe was
prepared. The primer pairs 2f/3r, 4f/5r, 6f/7r, and 8f/9r
were used to amplify the internal sequence of ETn. The
amplified DNAs approx 0.3 kb in size were purified with
a Wizard PCR Prep (Promega) and were labeled with 32P
sing a random primer labeling system (BRL). For expo-
ure and analysis of the blot membranes, an Imaging-
late and BAS2000 system (Fuji Photofilm Co.) were
sed. For RT-PCR, an RNA PCR Kit (Takara Shuzo Co.)
as used as specified by the manufacturer. In brief, 1.0
mg of poly(A)1 RNA purified by oligo(dT) Latex (Takara)
was reverse-transcribed using primers 3r, 5r, 7r, or 9r or
oligo(dT) adapter primer (Takara). The complementary
DNAs corresponding to the internal region of ETn RNA
were then amplified by PCR (25 cycles of 94°C for 1
min–55°C for 1 min–72°C for 2 min) using primer pairs 1f
(216–238 of M16478) 1 3r, 2f 1 5r, 4f 1 7r, 6f 1 9r, or 8f 1
0r (5402–5380). RNA samples without reverse transcrip-
tase were used as negative controls.
RACE and sequencing
Construction of a lEMBL3 library from C3H liver DNA
nd plaque hybridization to isolate ETn-positive clones
robed by ETn LTR were done by the standard methods
Maniatis et al., 1982). To amplify the 59 end and 39 end
f ETn RNA, the rapid amplification of cDNA ends
ethod was performed using a 59-Full RACE Core Set
nd 39-Full RACE Core Set (Takara). Poly(A)1 RNA was
nriched from total RNA using oligo(dT) Latex (Takara).or 39 RACE, a seminested PCR was done using two
orward primers (4679–4700 and 4891–4913) and a back-
ard primer (oligo(dT) primer). For 59 RACE, single-
tranded cDNA reverse transcribed from RNA using a
ackward primer (864–844) was circularized using T4
NA ligase. The sequence corresponding to the 59 RNA
as amplified by inverted PCR with the primer set 732–
12 and 744–765. The products were further amplified
sing a primer set (709–688 and 813–833) for nested
CR. Both 59 and 39 RACE products were cloned using
MOS-blue vector (Amersham) and sequenced using
equenase II dCTP kit (Strategene).
uclear extract and electrophoretic mobility-shift
ssay
Preparation of nuclear extract and EMSA assay were
one based on the standard method (Dignam et al.,
983). In brief, 4 3 108 cells were washed with phos-
phate-buffered saline and then with hypotonic buffer
containing 10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM
Cl, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), and
.5 mM dithiothreitol (DTT). Nuclei prepared by homog-
nization were resuspended with equal volumes of low-
alt buffer (20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 20 mM
Cl, 0.5 mM DTT, 80 mM EDTA, 0.2 mM PMSF, and 25%
lycerin) and high-salt buffer (the KCl concentration of
he low-salt buffer was changed to 300 mM). After incu-
ation at 0°C for 30 min, the mixture was centrifuged at
5,000g for 30 min at 4°C . The supernatant was dia-
yzed with 20 mM HEPES (pH 7.9), 100 mM KCl, 0.8 mM
DTA, 0.2 mM PMSF, 0.5 mM DTT, and 20% glycerin. The
rotein concentrations of leukemia lines and normal
ells were measured and made the same by dilution.
leven sites of LTR sequence overlap were tested in this
tudy and results are shown in Fig. 4a. A pair of the
ynthetic oligonucleotides was annealed and the 59 ends
ere labeled with 32P using T4 polynucloetide kinase.
he labeled dsDNA oligomer was mixed with the nuclear
xtract in buffer containing 15 mM HEPES (pH 7.9), 50
M KCl, 0.1 mM EDTA, 0.1 mM PMSF, 0.1 mM DTT, and
% glycerin, 0.25 mg/ml poly(dI/dC) oligomer, and 1
g/ml sonicated salmon sperm DNA. After incubation at
0°C for 60 min, the mixture was applied to a 6% poly-
crylamide gel and electrophoresed.
ucleotide sequence accession numbers
The ETn sequences reported in this study have been
eposited with DDBJ/EMBL/GenBank under Accession
os. AB033507 to AB033525.
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